Tag: Emgality

May 2, 2019 Off

Lilly presents new Emgality data

Eli Lilly will present 19 scientific abstracts for headache preventive drug Emgality (galcanezumab-gnlm) and lasmiditan at the 71st Annual Meeting of the American Academy of Neurology (AAN) taking place in Philadelphia from May 4-10, 2019.

March 5, 2019 Off

FDA grants Priority Review for Eli Lilly’s sBLA for Emgality injection to prevent cluster headache

By Dino Mustafić

FDA has granted Priority Review for Eli Lilly’s sBLA for Emgality (galcanezumab-gnlm) injection for the preventive treatment of episodic cluster headache in adults, the company said Tuesday in a press release.